← ANALYST RATINGS · TIPRANKS

Ceribell, Inc. (CBLL): analyst forecast and price target

$25.04 −9.41% close 16.10.26 · market cap $1.1B · General · Medical - Devices IWM 0.03%
Price targets and ratings of

Analyst consensus

Strong Buy

3 Buy0 Hold0 Sell

Ratings of 3 analysts in the last 3 months · top analysts only

12-month forecast

$29.50+17.8% upside

Based on 3 price targets given in the last 3 months, the average target is $29.50, the highest $33.00, the lowest $26.00. The average is +17.8% from the last price of $25.04.

$10.00$20.00$30.00Jan 26AprJulOctJan 27AprJulOctHigh$33.00Average$29.50Low$26.00
Highest target $33.00 Average target $29.50 Lowest target $26.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Josh Jennings★★★★★★★★★★#3537 · hits 46% · avg +3.0% TD Cowen $29.00 → $33.00+13.8% Buy +31.8% Reiterated 02.10.26on TipRanks 01:30 −0.4%next day +4.3% · 5 days −1.4%
Brandon Vazquez★★★★★★★★★★#11688 · hits 42% · avg −5.1% William Blair — Buy — Reiterated 30.09.26on TipRanks 15:06 −1.7%next day −3.4% · 5 days −5.6%
Marie Thibault★★★★★★★★★★#12343 · hits 40% · avg −9.7% BTIG $30.00 Buy +19.8% Reiterated 21.09.26on TipRanks 08:15 −2.0%next day 0.0% · 5 days +2.1%
Unknown Analyst Raymond James $29.00 Buy +15.8% Reiterated 03.09.26on TipRanks Sep 4 04:45 −2.0%next day +1.0% · 5 days −2.7%
William Plovanic★★★★★★★★★★#5377 · hits 43% · avg +1.3% Canaccord Genuity $26.00 Buy +3.8% Reiterated 13.08.26on TipRanks Aug 11 07:05 +10.7%next day +7.3% · 5 days +14.0%
Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% Bank of America Securities — Buy — Reiterated 11.08.26on TipRanks 11:05 +10.7%next day +7.3% · 5 days +14.0%
Josh Jennings★★★★★★★★★★#3537 · hits 46% · avg +3.0% TD Cowen $29.00 Buy +15.8% Reiterated 05.08.26on TipRanks Aug 10 10:18 −1.0%next day −0.1% · 5 days +24.9%
Jeffrey Cohen★★★★★★★★★★#11115 · hits 35% · avg −2.9% Ladenburg Thalmann & Co. $32.00 Buy +27.8% Reiterated 12.05.26on TipRanks May 13 05:15 −16.3%next day +6.4% · 5 days +1.9%
Robbie Marcus★★★★★★★★★★#1974 · hits 51% · avg +6.5% J.P. Morgan $17.00 Buy −32.1% Reiterated 05.11.25on TipRanks 08:30 +7.5%next day −0.8% · 5 days +8.2%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering Ceribell, Inc.

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Brandon Vazquez★★★★★★★★★★William Blair · #11688
Hits 42%73 of 175 Average return −5.1%
1 year Brandon Vazquez★★★★★★★★★★William Blair · #11688
Hits 42%73 of 175 Average return −5.1%
2 years Brandon Vazquez★★★★★★★★★★William Blair · #11688
Hits 42%73 of 175 Average return −5.1%

Most profitable

3 months Brandon Vazquez★★★★★★★★★★William Blair · #11688
Hits 42%73 of 175 Average return −5.1%
1 year Brandon Vazquez★★★★★★★★★★William Blair · #11688
Hits 42%73 of 175 Average return −5.1%
2 years Brandon Vazquez★★★★★★★★★★William Blair · #11688
Hits 42%73 of 175 Average return −5.1%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $28.50 at a price of $24.39 (+16.9%); now: $29.50 at $25.04 (+17.8%).

$24.00$26.00$28.00Sep 15Oct 1Oct 15Top analysts$29.50Average target$29.50Price$25.04

PriceAverage targetTop analysts’ target

Recommendation trend · top analysts

02571051Oct 2542Nov45Dec37Jan 2618Feb15Mar15Apr6May16Jun14Jul23Aug13Sep14Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy011211
Buy664334
Hold000000
Sell000000

Earnings and sales forecast

Next report: 17.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $-0.51 (from $-0.55 to $-0.45). Last quarter: $-0.51.

Sales

Next quarter’s sales estimate — $29M (from $29M to $30M). Last quarter: $28M.

Best top-analyst consensus in the sector · General

STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
About Ceribell, Inc.
  • CEO: Xingjuan Chao
  • Employees: 327
  • 360 North Pastoria Avenue, Sunnyvale, CA, 94085, US
  • ceribell.com

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.

Data from the stock’s TipRanks forecast page, read 124 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗